These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1461 related articles for article (PubMed ID: 24671016)
1. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension. Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016 [TBL] [Abstract][Full Text] [Related]
2. Blood pressure lowering effects of β-blockers as add-on or combination therapy: A meta-analysis of randomized controlled trials. Guo QH; Zhu ZM; Feng YQ; Lin JX; Wang JG J Clin Hypertens (Greenwich); 2023 Mar; 25(3):227-237. PubMed ID: 36756690 [TBL] [Abstract][Full Text] [Related]
3. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs. Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022 [TBL] [Abstract][Full Text] [Related]
4. Does Antihypertensive Drug Class Affect Day-to-Day Variability of Self-Measured Home Blood Pressure? The HOMED-BP Study. Asayama K; Ohkubo T; Hanazawa T; Watabe D; Hosaka M; Satoh M; Yasui D; Staessen JA; Imai Y; J Am Heart Assoc; 2016 Mar; 5(3):e002995. PubMed ID: 27009620 [TBL] [Abstract][Full Text] [Related]
5. Association of the optic disc structure with the use of antihypertensive medications: the thessaloniki eye study. Harris A; Topouzis F; Wilson MR; Founti P; Kheradiya NS; Anastasopoulos E; Gong G; Yu F; Jonescu-Cuypers CP; Pappas T; Koskosas A; Coleman AL J Glaucoma; 2013 Sep; 22(7):526-31. PubMed ID: 22411020 [TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockers shorten the periodicity of ultradian variation in blood pressure in patients with essential hypertension. Kawamura H; Mitsubayashi H; Saito T; Kanmatsuse K; Saito N Hypertens Res; 1998 Sep; 21(3):179-86. PubMed ID: 9786602 [TBL] [Abstract][Full Text] [Related]
7. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment]. Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399 [TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management. Petrella R; Michailidis P Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126 [TBL] [Abstract][Full Text] [Related]
9. Analysis of antihypertensive treatment using real-world Japanese data-the retrospective study of antihypertensives for lowering blood pressure (REAL) study. Ohishi M; Yoshida T; Oh A; Hiroi S; Takeshima T; Otsuka Y; Iwasaki K; Shimasaki Y Hypertens Res; 2019 Jul; 42(7):1057-1067. PubMed ID: 30842611 [TBL] [Abstract][Full Text] [Related]
10. Differential Effects of Combination of Renin-Angiotensin-Aldosterone System Inhibitors on Central Aortic Blood Pressure: A Cross-Sectional Observational Study in Hypertensive Outpatients. Pradhan A; Vishwakarma P; Bhandari M; Sethi R; Narain VS Cardiovasc Ther; 2020; 2020():4349612. PubMed ID: 32983258 [TBL] [Abstract][Full Text] [Related]
11. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
12. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Hermida RC; Ayala DE; Fernández JR; Mojón A; Smolensky MH; Fabbian F; Portaluppi F Chronobiol Int; 2013 Mar; 30(1-2):280-314. PubMed ID: 23077971 [TBL] [Abstract][Full Text] [Related]
13. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses. Thomopoulos C; Parati G; Zanchetti A J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720 [TBL] [Abstract][Full Text] [Related]
14. Antihypertensive therapy and short-term blood pressure variability. de la Sierra A; Mateu A; Gorostidi M; Vinyoles E; Segura J; Ruilope LM J Hypertens; 2021 Feb; 39(2):349-355. PubMed ID: 33031167 [TBL] [Abstract][Full Text] [Related]
15. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916 [TBL] [Abstract][Full Text] [Related]
16. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension. Morgan TO; Anderson AI; MacInnis RJ Am J Hypertens; 2001 Mar; 14(3):241-7. PubMed ID: 11281235 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis. Jeffers BW; Robbins J; Bhambri R Am J Ther; 2017; 24(1):e68-e80. PubMed ID: 26588586 [TBL] [Abstract][Full Text] [Related]
18. Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system. Sim JJ; Bhandari SK; Shi J; Kalantar-Zadeh K; Rasgon SA; Sealey JE; Laragh JH Am J Hypertens; 2012 Mar; 25(3):379-88. PubMed ID: 22158065 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological interventions for hypertension in children. Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305 [TBL] [Abstract][Full Text] [Related]
20. Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment. Omboni S; Kario K; Bakris G; Parati G J Hypertens; 2018 Apr; 36(4):720-733. PubMed ID: 29045341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]